Clinical Research Directory

Inclusion Criteria: * History of prior radical prostatectomy for prostate cancer * Two PSA values \>= 0.2 ng/mL at least 4 weeks after prostatectomy * Patients who have started radiographic evaluation and underwent CT scan and/or bone scan prior to registration to the study will be able to participate under a late registration provision, provided that the more modern scans (WB/axial MRI and F-18 NaF PET/CT) can be completed within 8 weeks after CT scan and bone scan Exclusion Criteria: * Patients with known metastatic disease * PSA recurrence not verified by elevated PSA as discussed in the eligibility section * Patients who initiated androgen deprivation therapy or other systemic therapy (chemotherapy, immunotherapy, targeted therapy) for PSA recurrence; nutritional supplements used for treatment of PSA recurrence will be allowed